AxoGen Inc
NASDAQ:AXGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
Grail Inc
F:NL0
|
US |
|
ABO Energy GmbH & Co KgaA
F:AB9
|
DE |
|
IPH Ltd
F:1IP
|
AU |
Intrinsic Value
Is AXGN undervalued or overvalued?
See the intrinsic value estimate for
AxoGen Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What AxoGen Does
AxoGen makes medical products used to repair and protect damaged peripheral nerves, the nerves outside the brain and spinal cord. Its main products are used by surgeons in procedures for traumatic injuries and other nerve damage, especially when a cut or loss of nerve tissue needs a bridge or protective wrap to help the nerve heal. The company’s business is built around selling these implantable nerve repair products to hospitals, surgical centers, and doctors who perform reconstructive and trauma surgery.
- Headquarters
- United States of America US
- Employees
- 622
- IPO date
- Dec 17, 1986
Revenue & Expenses Breakdown
AxoGen Inc
Earnings Waterfall
AxoGen Inc
The intrinsic value for
AxoGen Inc (AXGN) under the Base Case is hidden USD.
Compared with the current market price of 49.85 USD, the stock appears hidden.